Exposure–Response Relationships for the Efficacy and Safety of Risankizumab in Japanese Subjects with Psoriasis - Suleiman, Ahmed A.; Khatri, Amit; Oberoi, Rajneet K.; Othman, Ahmed A. (Clinical pharmacokinetics, 2020)
Keywords: Arthritis; Clinical trials; Cytokines; FDA approval; Internal Medicine; Light therapy; Medicine; Medicine & Public Health; Monoclonal antibodies; NCT; NCT02054481; NCT02672852; NCT02684357; NCT02684370; NCT02694523; NCT03000075; NCT03022045; Original Research Article; Patients; Pharmacokinetics; Pharmacology/Toxicology; Pharmacotherapy; Psoriasis; Skin; Studies; Japan